Literature DB >> 3094307

Influence of the assay method used on the selection of the most active forms of FSH from the human pituitary.

L Wide, B Hobson.   

Abstract

The biological properties of different forms of human pituitary FSH, varying in their molecular charge, were investigated. FSH in two individual human pituitaries and a pool of 30 human pituitaries was extracted and subjected to electrophoresis. From each electrophoresis 14 consecutive fractions with the highest RIA activity were examined with in vitro and in vivo bioassays. The in vitro assay was based upon the estimation of oestradiol produced by cultured Sertoli cells from 10 day old rats. The in vivo bioassay was an hCG augmented test using immature female mice injected on 3 consecutive days. The increase in ovarian weight was the index of response. Both in the individual and in the pooled pituitary material the less negatively charged forms had the highest activity in the in vitro bioassay. In contrast, the more negatively charged forms had the highest activity in the in vivo bioassay. Forms of FSH from each of the two individual pituitary extracts were pooled according to their migration rate and injected iv into mice. The amount of FSH remaining in the circulation of the mouse after 1 h was related to the molecular charge. The highest value was obtained with the pool containing the more negatively charged forms of the hormone. The results indicate that the disappearance rate of the FSH molecule is a dominant factor in the in vivo bioassay. A consequence of these observations will be that the assay method chosen to monitor the purification of FSH will have a major influence on the biological properties of the final preparation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3094307     DOI: 10.1530/acta.0.1130017

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  13 in total

1.  Efficacy of a combined protocol of urinary and recombinant follicle-stimulating hormone used for ovarian stimulation of patients undergoing ICSI cycle.

Authors:  Arianna Pacchiarotti; Cesare Aragona; Renzo Gaglione; Helmy Selman
Journal:  J Assist Reprod Genet       Date:  2007-07-26       Impact factor: 3.412

Review 2.  In vitro bioassays of follicle-stimulating hormone: methods and clinical applications.

Authors:  M Simoni; E Nieschlag
Journal:  J Endocrinol Invest       Date:  1991-12       Impact factor: 4.256

3.  Receptor binding activity and in vitro biological activity of the human FSH charge isoforms as disclosed by heterologous and homologous assay systems: implications for the structure-function relationship of the FSH variants.

Authors:  E Zambrano; T Zariñán; A Olivares; J Barrios-de-Tomasi; A Ulloa-Aguirre
Journal:  Endocrine       Date:  1999-04       Impact factor: 3.633

4.  Biological activity and metabolic clearance of recombinant human follicle stimulating hormone produced in Sp2/0 myeloma cells.

Authors:  C K Chin; P R Schofield; D M Robertson; P P Gray; W Chotigeat; S M Mahler
Journal:  Cytotechnology       Date:  1996-06       Impact factor: 2.058

5.  Evaluation of in vivo bioactivities of recombinant hypo- (FSH21/18) and fully- (FSH24) glycosylated human FSH glycoforms in Fshb null mice.

Authors:  Huizhen Wang; Jacob May; Viktor Butnev; Bin Shuai; Jeffrey V May; George R Bousfield; T Rajendra Kumar
Journal:  Mol Cell Endocrinol       Date:  2016-08-22       Impact factor: 4.102

6.  Serum half-life of pituitary gonadotropins is decreased by sulfonation and increased by sialylation in women.

Authors:  Leif Wide; Karin Eriksson; Patrick M Sluss; Janet E Hall
Journal:  J Clin Endocrinol Metab       Date:  2008-12-30       Impact factor: 5.958

7.  Partially deglycosylated equine LH preferentially activates beta-arrestin-dependent signaling at the follicle-stimulating hormone receptor.

Authors:  Vanessa Wehbi; Thibaud Tranchant; Guillaume Durand; Astrid Musnier; Jérémy Decourtye; Vincent Piketty; Vladimir Y Butnev; George R Bousfield; Pascale Crépieux; Marie-Christine Maurel; Eric Reiter
Journal:  Mol Endocrinol       Date:  2010-01-27

8.  Naturally Occurring Follicle-Stimulating Hormone Glycosylation Variants.

Authors:  John S Davis; T Rajendra Kumar; Jeffrey V May; George R Bousfield
Journal:  J Glycomics Lipidomics       Date:  2014

Review 9.  Profile of follitropin alpha/lutropin alpha combination for the stimulation of follicular development in women with severe luteinizing hormone and follicle-stimulating hormone deficiency.

Authors:  Leonardo Rinaldi; Helmy Selman
Journal:  Int J Womens Health       Date:  2016-05-25

10.  Low- and Fully N-Glycosylated Gonadotropins Circulating in Women With Polycystic Ovary Syndrome.

Authors:  Leif Wide; Tord Naessén; Inger Sundström-Poromaa; Karin Eriksson
Journal:  J Endocr Soc       Date:  2021-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.